Future drug treatments for type 2 diabetes

Clifford J. Bailey*

*Corresponding author for this work

Research output: Chapter in Book/Published conference outputChapter

Original languageEnglish
Title of host publicationTextbook of diabetes
EditorsRichard I.G. Holt, Clive S. Cockram, Allan Flyvbjerg, Barry J. Goldstein
Number of pages28
ISBN (Electronic)978-1-4443-2480-8
ISBN (Print)978-1-4051-9181-4
Publication statusPublished - 9 Jul 2010


  • classification of new antidiabetic agents
  • development of new antidiabetic agents
  • endothelial nitric oxide synthase (eNOS)
  • inhibitors of intestinal carbohydrate digestion and absorption
  • insulin receptor and early post-receptor potentiation
  • insulin receptor substrate 1 (IRS1)
  • other insulin receptor potentiators
  • peroxisome proliferator-activated receptor γ agonists
  • potentiators of insulin secretion
  • sulfonylurea receptor 1
  • SUR1
  • Oral antidiabetic agents

    Bailey, C. J. & Krentz, A. J., 9 Jul 2010, Textbook of diabetes. Holt, R. I. G., Cockram, C. S., Flyvbjerg, A. & Goldstein, B. J. (eds.). 4th ed. Wiley-Blackwell, p. 452-477 26 p.

    Research output: Chapter in Book/Published conference outputChapter

Cite this